1. Home
  2. WOLF vs RAPP Comparison

WOLF vs RAPP Comparison

Compare WOLF & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wolfspeed Inc.

WOLF

Wolfspeed Inc.

N/A

Current Price

$26.38

Market Cap

1.5B

Sector

Technology

ML Signal

N/A

Logo Rapport Therapeutics Inc.

RAPP

Rapport Therapeutics Inc.

N/A

Current Price

$26.25

Market Cap

1.4B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
WOLF
RAPP
Founded
1987
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.4B
IPO Year
2025
2024

Fundamental Metrics

Financial Performance
Metric
WOLF
RAPP
Price
$26.38
$26.25
Analyst Decision
Hold
Strong Buy
Analyst Count
2
16
Target Price
$25.00
★ $64.21
AVG Volume (30 Days)
★ 3.3M
1.4M
Earning Date
11-04-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 24.34
EPS
N/A
★ N/A
Revenue
★ $1,385,982,000.00
N/A
Revenue This Year
$14.87
N/A
Revenue Next Year
$4.07
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 19.00
N/A
52 Week Low
$13.49
$22.06
52 Week High
$80.82
$52.93

Technical Indicators

Market Signals
Indicator
WOLF
RAPP
Relative Strength Index (RSI) 53.30 43.33
Support Level $23.31 $22.06
Resistance Level $26.70 $31.49
Average True Range (ATR) 2.23 2.26
MACD 0.19 0.45
Stochastic Oscillator 95.42 48.78

Price Performance

Historical Comparison
WOLF
RAPP

About WOLF Wolfspeed Inc.

Wolfspeed Inc is an innovator of wide bandgap semiconductors, focused on silicon carbide materials and devices for power applications. Its product families include silicon carbide materials and power devices. Its products are targeted for various applications in the Automotive domain, including electric vehicles and fast charging, as well as existing and emerging applications in the Industrial & Energy domain such as AI data centers, grid modernization and renewable energy and storage as well as aerospace and defense. The company also use contract manufacturers, some of which include captive lines, for certain products and aspects of product fabrication, assembly and packaging. The company has one reportable segment. Majority of revenue comes from United States followed by Hong Kong.

About RAPP Rapport Therapeutics Inc.

Rapport Therapeutics Inc is a clinical-stage biotechnology company dedicated to the discovery and development of small-molecule precision medicines for patients with neurological or psychiatric disorders. The company's portfolio of programs from its RAP technology platform includes RAP-219, an investigational small molecule being developed as a therapy for focal onset seizures, primary generalized tonic-clonic seizures, and bipolar mania. Additionally, it has two discovery-stage nicotinic acetylcholine receptor (nAChR) programs stemming from its RAP technology platform: one being developed for the treatment of chronic pain, and the second, being developed for the treatment of hearing disorders. Geographically, the company operates in the United States.

Share on Social Networks: